Virtual Reality in Rehabilitation of Executive Functions in Children With Attention Deficit Hyperactivity Disorder.
VREALFUN-ADHD
1 other identifier
interventional
88
1 country
1
Brief Summary
Attention deficit hyperactivity disorder (ADHD) is caused by an abnormality in the development of the central nervous system. Children with attention and executive function difficulties often need long-lasting rehabilitation and there is an increasing need for timely, cost-effective, and feasible rehabilitation interventions, where the training is targeted to support everyday life functional capacity. The use of Virtual Reality (VR) in the rehabilitation of children with attention and executive function deficits offers opportunities to practice skills required in everyday life in environments emulating real-life situations. The major aim of this research project is to develop a novel effective VR rehabilitation method for children with deficits in attention, activity control and executive functions by using the virtual environment that corresponds to the typical everyday life. In this randomized control study VR glasses are used to present the tasks, and the levels of difficulty are adjusted according to the child's progress. Researchers expect that; 1) Intensive training improves the attention regulation, activity control skills and executive functions of the children in the intervention group; 2) Training of executive skills with motivating tasks in a virtual environment that is built to meet challenging everyday situations transfers to the child's everyday life, 3) The duration of the training effect does not depend on the success of the VR training itself, but on how well the child adopts new strategies that make everyday life easier and how the parent is able to support the child's positive behaviour in everyday life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2023
CompletedFirst Posted
Study publicly available on registry
November 9, 2023
CompletedStudy Start
First participant enrolled
January 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 5, 2025
August 1, 2025
2 years
September 28, 2023
August 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Epeli (Executive Performance in Everyday LIving) task
A virtual reality task for attention, executive function, and prospective memory. Change in total score, task efficacy, navigation efficacy, controller motion, and total action.
Baseline, 4-6 weeks, 6 months and 12 months.
ADHD-rating scale IV (ADHD-RS) (parent report)
The ADHD-RS (parent report) is an assessment of a child's ADHD symptoms with 18 items based on the child's behaviour over the past 6 months. 4-point Likert scale. The total score ranges 0-54, scores in inattention subscale and hyperactivity/impulsivity subscale range 0-27. Change in the total score, inattention subscale score, and hyperactivity/impulsivity subscale score on a parent-rated ADHD-RS. A lower score means a better outcome.
Baseline, 4-6 weeks, 6 months and 12 months.
Epeli Questionnaire (parent report)
An assessment of a child's functional ability and the amount of positive feedback given by the parent to the child over the past 4 weeks. 5-point Likert scale. 2 subscales: Functional ability subscale where score ranges 4-20, and Positive feedback subscale where score ranges 4-20. Change in Functional ability subscale score and Positive feedback subscale score on parent-rated Epeli- questionnaire. A higher score means a better outcome.
Baseline, 4-6 weeks, 6 months and 12 months.
Epeli Questionnaire (child report)
An assessment of a child's functional ability and the amount of positive feedback given by the parent to the child over the past 4 weeks. 5-point Likert scale. 2 subscales: Functional ability subscale where score ranges 4-20, and Positive feedback subscale where score ranges 4-20. Change in Functional ability subscale score and Positive feedback subscale score on child-rated Epeli- questionnaire. A higher score means a better outcome.
Baseline, 4-6 weeks, 6 months and 12 months.
Secondary Outcomes (7)
Behavior Rating Inventory of Executive Function (BRIEF-2) (parent form)
Baseline, 4-6 weeks, 6 months and 12 months.
Behavior Rating Inventory of Executive Function (BRIEF-2) (teacher form)
Baseline, 4-6 weeks, 6 months and 12 months.
Concentration questionnaire (in Finnish: Keskittymiskysely)
Baseline, 4-6 weeks, 6 months and 12 months.
Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents Revised Version ( KINDL-R) (parent version)
Baseline, 4-6 weeks, 6 months and 12 months.
Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents Revised Version (KINDL-R) (self-report version)
Baseline, 4-6 weeks, 6 months and 12 months.
- +2 more secondary outcomes
Study Arms (4)
Parental Guidance+Virtual Reality Game
EXPERIMENTALParental Guidance
EXPERIMENTALVirtual Reality Game
EXPERIMENTALControl Group
NO INTERVENTIONThis group implement the rehabilitation plan drawn up in specialized medical care (treatment as usual).
Interventions
Parents get guidance for children's positive behaviour support by using parts of Self-Help Program on the MentalHub.fi (in Finnish: Mielenterveystalo.fi) website regarding children's challenging behaviour (in Finnish: Lasten haastavan käytöksen omahoito-ohjelma) .
Virtual reality game for rehabilitation of attention, activity control and executive functions by using the virtual environment that corresponds to the typical everyday situations at home.
Eligibility Criteria
You may qualify if:
- Diagnosis of ADHD (ICD-10 F90.0) and
- Methylphenidate medication and
- Age 8-12 years and
- Finnish as a native language
You may not qualify if:
- Sensitivity to flashing light,
- Epilepsy (ICD-10 G40),
- Mental retardation (ICD-10 F70-F79),
- Pervasive developmental disorders (ICD-10 F84),
- Inflammatory diseases of the central nervous system (ICD-10 G00-G09),
- Severe cerebral palsy syndrome (ICD-10 G80, GMFCS 4-5, MACS 3-5),
- Traumatic brain injury ((ICD-10 S06),
- Brain tumour, and
- Multiple pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Merja Nikulalead
- University of Oulucollaborator
- Aalto Universitycollaborator
- University of Helsinkicollaborator
- Helsinki University Central Hospitalcollaborator
Study Sites (1)
Oulu University Hospital
Oulu, 90029, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Johanna Uusimaa, MD, PhD
Oulu University Hospital
- PRINCIPAL INVESTIGATOR
Merja Nikula, M.Psych.
Oulu University Hospital
- STUDY DIRECTOR
Mirjami Mäntymaa, MD, PhD
Oulu University Hospital
- STUDY DIRECTOR
Juha Salmitaival, PhD
University of Oulu, Finland
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 28, 2023
First Posted
November 9, 2023
Study Start
January 10, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
September 5, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share